SLNO — Soleno Therapeutics Share News
0.000.00%
Last trade - 00:00- $2.76bn
- $2.56bn
- $190.41m
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: EMA's CHMP Recommends Granting A Marketing Authorisation For Cenrifki (Tolebrutinib)
Soleno withdraws EU rare disease drug application ahead of Neurocrine takeover
HC Wainwright lifts PT on Neurocrine after Soleno deal
Brief: Soleno Therapeutics Inc - Withdraws Marketing Authorization Application For Viokat In Europe - SEC Filing
U.S. RESEARCH ROUNDUP-Centerspace, Union Pacific, XPO
US STOCKS-Wall St ends higher as investors parse US-Iran negotiations, threats
US STOCKS-Wall St ends higher as investors parse US-Iran negotiations, threats
Deals of the day-Mergers and acquisitions
US STOCKS-Wall St clings to gains as investors assess US-Iran negotiations, threats
U.S. STOCKS ON THE MOVE-Tesla, Norfolk Southern, Denali
U.S. STOCKS ON THE MOVE-Tyson Foods, Atmus Filtration, Avis Budget
Soleno jumps to over one-year high as Neurocrine strikes $2.9 bln takeover deal
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Legence, Valero Energy, Stereotaxis
NASDAQ RESUMED AT 09:00 AM
U.S. STOCKS ON THE MOVE-Soleno Therapeutics, Ideaya Biosciences, Profusa